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Introduction  
Recently plant viruses have been exploited 
as an alternative production method for 
pharmaceutically important peptides [1-9]. 
Antigenic peptides that were produced 
through this approach have been shown to be 
immunogenic. Thus, chimeric plant virus 
vector could be used as vaccine production 
system. Immunological studies also showed 
that chimeric virus based vaccine can be 
administered both orally and through 
subcutaneous route [10, 11]. This makes 
chimeric virus vector a new, safe, versatile 
and cost effective method for vaccine 
production. 
The “a” determinant of the hepatitis B 
surface antigen (HBsAg) is present in all 
serotypes of HBV; it has been used as the 
basis for almost all HBsAg diagnostic kit and 
vaccine development.  
The “a” determinant of HBsAg is a 
conformational epitope. Although the 
structure of HBsAg has yet to be determined, 
physical properties of HBsAg have been very 
well characterized. The epitope is heavily 
cross-linked through disulfide bridges [12], 
and glycosylated at several sites [12-15]. In 
vitro production of HBsAg will have to 
maintain the epitope in correct conformation 
and proper post-translational modification is 
necessary to maintain its antigenicity and 
antibody binding capabilities [11, 15-18]. That 
is why the HBsAg cannot be produced in 
prokaryotic system. Plant based production 
system has been developed [17]. The HBsAg 
produced from the system was shown to be 
antigenic, and binds to specific HBsAg 
monoclonal antibody.  
We have successfully constructed a novel 
Cucumber Green Mottle Mosaic Virus 
(CGMMV) vector, and base on this vector a 
chimeric CGMMV vector was built. Both 
constructs were used to produce infectious 
transcript that was later used to inoculate 
muskmelon plants. The coat protein of the  
chimeric virus vector produces chimeric 
CGMMV that randomly displayed HBsAg on 
the surface. It produces two types of coat 
proteins; the native coat protein and 
recombinant coat protein that have HBsAg “a” 
determinant fused to the C-terminal. The 
present of HBsAg on the virus particles was 
successfully detected using commercial 
HBsAg diagnostic kit. 
 
Materials and methods. 
 
The CGMMV vector and the chimeric 
CGMMV vector. 
The map of the CGMMV vector that was 
constructed for use as vaccine production 
system (pCGT7X) is shown in (Figure 1). The 
pCGT7X was used to construct chimeric 
CGMMV vector. The map of the chimeric 
CGMMV vector (pCGHB310803) is shown in 
(Figure 2). The pCGHB310803 was 
constructed by ligating the HBsAg coding 
sequence into the Hind III restriction site of 
the pCGT7X and amber stop codon of the 
CGMMV coat protein gene was modified to 
accommodate amber stop read through 
sequence. 
 
Preparation of in vitro transcription template 
DNA. 
Template for in vitro transcription was 
synthesized in a 50µl PCR reaction. The 
reaction contained 1x Thermopolymerase 
buffer (NEB) with MgSO4 concentration 
adjusted to 3mM, 200µM of PCR nucleotide 
mix (Finzymes), 1µM of each forward and 
reverse primer (sequences are not shown due 
to patenting requirement), 15ng of pure 
pCGHB310803 or pCGT7X, 2U of 
DeepVentR® DNA polymerase (NEB) and 1U 
of Taq DNA polymerase (Promega). The PCR 
cycles were as follows: 95oC initial 
denaturation for 3 minutes, followed by 32 
cycles of 98oC denaturation for 10 second, and 
65oC annealing and elongation for 7 minutes. 
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The PCR product was purified through two 
rounds of phenol-chloroform extractions 
followed by ethanol-Lithium precipitation. 
The precipitated DNA was then reconstituted 
in 10µl of ultra-pure water for each 50µl of 
starting PCR product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1 The schematic diagram of the pCGT7X 
The cDNA of the CGMMV and T7 promoter are 
clone into a Hind III deletion variant of pUC19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2 The schematic diagram of the 
pCGHB310803. The HBsAg “a” determinant 
coding sequence is cloned down stream of the CP 
gene. The expression of the HBsAg is controlled 
by leaky UAG sequence. 
 
In vitro transcription to produce infectious 
RNA transcript.  
The in vitro transcription reaction was 
carried out using Ambion® mMessage 
mMachineTM T7 kit, according to 
manufacturer protocol. 
 
Double antigen sandwiched (DAS) ELISA 
with MONOLISA HBsAg plus Diagnostic kit 
(BioRad). 
All reactions were carried out according to 
manufacturer protocol. 
 
Inoculation of infectious transcript onto 
muskmelon plants. 
Inoculation of infectious transcript onto 
muskmelon plants was carried out by mixing 
the transcription mix with inoculation buffer 
that contains (5% celite and 10% 
Diatomaceous Earth (Sigma), in 25mM Tris-
glycine buffer pH 7.5). The mixture is then 
rubbed onto cotyledons of 7 day-old 
muskmelon seedlings. 
 
RT-PCR to detect chimeric virus infection in 
muskmelon plants. 
Total RNA was isolated and purified from 
muskmelon plant using QIAGEN RNeasy 
Plant mini kit. 5µg of the RNA were then 
mixed with 0.5µM of primer CGMMV3’UTR 
(5’AAA GCA TGC TGG GCC CCT ACC 
CGG GGA A-3’), and 100µM of PCR 
nucleotide mix (Finzymes) in 13µl reaction 
mix. This reaction mix was heated to 65oC to 
denature the RNA followed by quick quench 
on ice. After that, 4µl of 5x First-strand buffer 
(InvitrogenTMTM), 1µl of 0.1M DTT, 1µl 
RNaseOUTTM (InvitrogenTM) and 200u of 
SuperscriptsTM III (InvitrogenTM) reverse 
transcriptase  
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FIGURE 3   Diagram shows the detection of chimeric virus infection. Two steps RT-PCR used for this 
purpose is designed to be highly specific for detection of chimeric CGMMV infection. First strand cDNA 
synthesis was carried out at using primer that is specific for the 3’ terminal of the viral RNA. Then PCR 
amplification of the HBsAg coding sequence was carried out using primers that are specific for the epitope 
coding sequence. 
 
 
were added and the final reaction volume was 
20µl. The reaction was carried out at 55oC for 
1 hour to synthesis the first strand cDNA. 
After the first strand synthesis, PCR was 
carried out with primer pair “PSTSENSE” (5’-
TAG GAA AAA ACC AGA AGA TCT GCA 
GGA ATT TTT CTC-3’and “HindAmberHB” 
(sequence not disclose due to patent 
requirement) this pair of primers flanks a 
region of around 2100 base pairs and the 
HindAmberHB is specific for HBsAg 
sequence (Figure 3). The PCR reaction was 
carried out in a 50µl reaction mix containing, 
1x Taq DNA polymerase buffer (Promega®), 
1.5mM MgCl2, 0.5µM of PCR nucleotide mix 
(Finzymes), 100µM of each primer, 2µl of 
first strand DNA, and 2U of Taq DNA 
polymerase (Promega). The PCR cycle 
condition was initial denaturation at 95oC for 3 
minutes, and 30 cycles of denaturation at 98oC 
for 10 seconds, annealing at 60oC for 30 
seconds and 72oC for 2 minutes. 
 
Virus purification. 
Virus isolation and purification was carried 
out according to the method reported by [19]. 
Virus infected plant materials were frozen 
overnight in –20oC. 1ml per-gram-plant 
material of phosphate buffer (0.1M, pH 7.5) 
containing 0.1% β-mercaptoethanol was added 
to frozen infected plant materials and then the 
plant material was homogenized with food 
processor. The homogenized plant material 
was then sieved through two layers of muslin 
cloth. After that, while stirring, equal volume 
of butanol:chloroform (1:1) was then added to 
the filtrate. The mixture was further stirred for 
another 30 minutes. The coagulated plant 
materials (chloroplast) and organic solvents 
were separated through centrifugation at 
10,000g for 30 minutes. After that, 4g of 
Sodium Chloride and 4g of PEG 6000 were 
then added to each 100ml of supernatant. The 
mixture was stirred until all the NaCl and the 
PEG 6000 dissolved. The mixture was then 
stored overnight at 4oC to further precipitate 
the virus. On the second day, the precipitated 
virus particle was separated from the solution 
through centrifugation at 10,000g for 30 
minutes. The virus pellet was then re-
suspended in 20ml of ultra-pure water for each 
100ml of initial plant extract. The virus 
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suspension was then cleared by centrifugation 
at 10,000g for 15 minutes. After this 
centrifugation step, 5ml of 0.2M EDTA was 
added to each 100ml of supernatant. The 
mixture was then subjected to ultra-
centrifugation at 110,000g for 1 hour 30 
minutes at 4oC. After the ultra-centrifugation 
step, the pellet, which contained the virus, was 
then re-suspended in ultra-pure water again. 
Then, the unresolved materials in the 
suspension were separated by centrifugation at 
10,000g for 15minutes. These cycles of high-
speed and low-speed centrifugations were 
carried out until the pellet is clear. The final 
virus pellet was re-suspended in ultra-pure 
water. 
 
Result and discussion 
The CGMMV virus vector (pCGT7x) that 
was constructed has the first nucleotide of the 
viral genome located at the +2 position of the 
T7 promoter, where the +1 position was an 
extra-viral Guanidine nucleotide. Thus, in 
theory, the extra viral Guanidine nucleotide 
will be transcribed into the m7GpppCap 
structure, therefore, the transcript would be 
almost identical to that of the native virus. 
However, after the vector was constructed, the 
shorten T7 promoter was found to be 
inefficient in generating transcript, because of 
that, not enough transcript was generated for 
inoculation purpose. Thus, the clone could not 
be used directly as transcription template. 
Since the +1 and +2 sequence after the T7 
promoter are essential for transcription 
efficiency [20], a pair of primers “T7doubleG” 
and “CGMMV3’UTR” were designed to carry 
out PCR to generate template for in vitro 
transcription. PCR product that is produced 
with this pair of primers will have an extra-
viral guanidine nucleotide at the 5’ end of This 
new PCR generated template performed well 
in transcription reaction (Figure 4). The in 
vitro synthesized transcripts were also used to 
inoculate cotyledons of seven-day old 
muskmelon seedling. Two weeks after 
inoculation, all inoculated muskmelon 
seedlings showed typical mosaic symptom. 
Infectivity of the in vitro synthesized 
transcript was also found to be to the same 
degree to that of purified viral RNA (result not 
show).  
 
 
FIGURE 4 In vitro synthesized RNA analyzed 
using 1% native agarose gel electrophoresis. The 
RNA samples were pre-denatured in 7M urea 
before loaded into the gel. The Dominant ~6k 
bases band is the in vitro synthesized RNA. 
 
The use of shorten T7 promoter to generate 
infectious viral transcript has been reported in 
several papers [21-25], however, there were 
also cases reported that the shorten T7 
promoter failed to produce any transcript at 
all. While some papers reported that extra-
viral nucleotide at the 5’ end will render the 
transcript to become non-infectious. The 
pCGT7X that was constructed in this study 
showed that the shorten T7 RNA polymerase 
promoter failed to effectively initiate 
transcription reaction. This could be due to the 
multiple adenine nucleotide repeat at the 5’ 
UTR region of the CGMMV genome. 
Multiple adenine nucleotides repeat directly 
after bacteriophages promoter have been 
found to cause premature abortion of 
transcription product[20, 26], as well as 
causing RNA polymerase to drop off the 
template. This is because the hydrogen bonds 
that hybridized adenine to Uracil is relatively 
weaker, and the interaction was suggested to 
stabilized ternary complex that formed among 
synthesized RNA, template DNA and the 
polymerase. Addition of an extra guanidine 
nucleotide to the +2 position of T7 RNA 
polymerase could have stabilized the ternary 
complex, thus resulting in transcription that is 
more efficient. The extra-viral guanidine 
nucleotide was also not causing any 
observable reduction in infectivity. Although 
direct comparison between transcript without 
extra-viral Guanidine nucleotide and the 
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transcript with extra-viral nucleotide was not 
able to carry out, preliminary infectivity study 
showed that there is no observable effect 
(result not show).  
Once it was confirmed that the 
transcription CGMMV vector is working, 
construction of chimeric CGMMV 
(pCGHB310803) that expressed HBsAg on its 
surface was carried out. This chimeric virus 
vector was designed in such a way that the 
production of recombinant fusion protein is 
controlled by a leaky UAG signal. 
Introduction of the leaky UAG signal will 
cause occasional translation read-through, 
resulting in a new monopartide virus that 
produces two different coat proteins.  
The chimeric virus vector was successfully 
constructed, and the in vitro transcription 
template was generated through the same PCR 
method that was developed for pCGT7x. The 
in vitro synthesized transcript was inoculated 
onto the cotyledons of seven-day old 
muskmelon seedling, and typical mosaic 
symptom was observed after two weeks post 
inoculation. Infected plants were further 
screened with RT-PCR to confirm that the 
symptom was indeed caused by the chimeric 
virus (Figure 5). 
 
         L        1        2        3       4       5 
 
 
FIGURE 5 RT-PCR product analyzed on 0.8% 
native agarose gel. Lane L was NEB 1kbp DNA 
ladder, lane 1 to lane 3 were sample results lane 4 
was negative control (native CGMMV infected 
leaves) while lane 5 was in vitro synthesized RNA.  
 
 
The mosaic symptom appeared on new 
leaves two weeks after the inoculation. This 
signified that the virus had moved from the 
inoculated leave to young leaves, and caused 
systemic infection. Since the movement of 
virus requires the virus to be assembled into 
virus particle [27, 28]. Systemic infection 
caused by the virus also showed that the 
present of the recombinant fusion protein does 
not hamper the assembly of virus particles. 
Furthermore, virus isolation procedure was 
also able to purify the virus particles. Even 
though the virus was able to assemble into 
particles, it does not mean that the 
recombinant fusion protein has taken part in 
the formation of virus particles. To test this 
ELISA was carried out to find out if the virus 
particles were indeed displaying the HBsAg 
peptide. Double antigen sandwich ELISA with 
commercial clinical diagnostic kit 
(MONOLISA® HBsAg Plus BioRadTM) 
showed the present of HBsAg in both infected 
plant materials and purified chimeric virus 
particles (Figure 6). The ability of the 
chimaric virus to bind monoclonal antibody 
specific to HBsAg shows that the presented 
peptide was in correct conformation.  
The ability to produce the chimeric virus 
displaying HBsAg in the correct conformation 
shows that this system is suitable for use as a 
production system for commercially important 
peptide and even small proteins.  
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FIGURE 6   ELISA detection of the present of HBs 
antigen. PBS and native CGMMV were used as 
negative control while purified HBsAg was used as 
positive control. The CGHB stands for chimeric 
CGMMV. 
 
 
While the mechanism of how the present the 
native coat protein help the production of 
viable virus is yet to be determined, a simple 
experiment where a mutant virus vector with 
the UAG at the leaky stop site replaced by 
CAA failed to produce viable virus (result not 
shown). This has further confirmed the 
important of the present of the native virus 
coat protein. 
Our group has rediscovered the use of 
translation read-through signal in CGMMV 
chimeric virus system to be advantageous and 
it is suitable to be used as a versatile, high 
yielding epitope production system.   
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